Your browser doesn't support javascript.
loading
Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer Therapy.
Zhu, Lichen; Yang, Xiaomei; Zhong, Dani; Xie, Shenxia; Shi, Wei; Li, Yangzi; Hou, Xiaoqiong; Zhou, Huihui; Zhao, Minlong; Ding, Ziqiang; Zhao, Xinyue; Mo, Fengzhen; Yin, Shihua; Liu, Aiqun; Lu, Xiaoling.
Afiliación
  • Zhu L; Nanobody Research Center, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Yang X; School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Zhong D; Nanobody Research Center, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Xie S; School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Shi W; Nanobody Research Center, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Li Y; Department of Chemotherapy, Affiliated Cancer Hospital, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Hou X; Nanobody Research Center, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • HuaYao; Nanobody Research Center, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Zhou H; Nanobody Research Center, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Zhao M; Guangxi Collaborative Innovation Center for Biomedicine, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Ding Z; Nanobody Research Center, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Zhao X; School of Preclinical Medicine, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Mo F; Nanobody Research Center, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Yin S; School of Stomatology, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Liu A; Nanobody Research Center, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Lu X; Guangxi Collaborative Innovation Center for Biomedicine, Guangxi Medical University, Nanning, Guangxi 530021, China.
J Immunol Res ; 2020: 2454907, 2020.
Article en En | MEDLINE | ID: mdl-32964055
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Inmunoterapia Adoptiva / Anticuerpos de Dominio Único / Receptores Quiméricos de Antígenos Límite: Animals / Humans Idioma: En Revista: J Immunol Res Año: 2020 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Inmunoterapia Adoptiva / Anticuerpos de Dominio Único / Receptores Quiméricos de Antígenos Límite: Animals / Humans Idioma: En Revista: J Immunol Res Año: 2020 Tipo del documento: Article País de afiliación: China